HAVAS INVESTOR RELATIONS: FIRST HALF REVENUE 2005

Havas today announced revenue of € 700 million for the first half of 2005 compared to € 748 million for the first half of 2004. The net impact of scope of consolidation changes in the first half was a negative € 50 million, due primarily to the disposal program completed in 2004. The impact of exchange rate variations was a negative € 14 million mainly due to the dollar and the pound sterling.

PharmaLive (http://www.medadnews.com/News/index.cfm?articleid=261576)